Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IC51 Japanese encephalitis vaccine long-term follow-up study
ACTRN12605000681651Phase 3Not yet recruiting
- Sponsor
- Intercell AG
- Start
- Oct 2006
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-arm trial of Japanese encephalitis inactivated vaccine in Japanese encephalitis (JE), sponsored by Intercell AG. Planned start Oct 2006; status: not yet recruiting.
02
Drugs
Japanese encephalitis inactivated vaccine
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on ACTRN12605000681651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12605000681651.